XML Template (2014) [28.8.2014–4:28pm] //blrnas3/cenpro/ApplicationFiles/Journals/SAGE/3B2/ACRJ/Vol00000/140134/APPFile/SG-ACRJ140134.3d
(ACR)
[1–8] [PREPRINTER stage]
Acta Radiol OnlineFirst, published on September 2, 2014 as doi:10.1177/0284185114545151
Original Article
Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator
Acta Radiologica 0(0) 1–8 ! The Foundation Acta Radiologica 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/0284185114545151 acr.sagepub.com
Xiao-Er Wei1,*, Yu-Wu Zhao2,*, Jing Lu1, Ming-Hua Li1, Wen-Bin Li1, Ya-Jun Zhou2 and Yue-Hua Li1
Abstract Background: Intravenous administration of recombinant tissue plasminogen activator (rtPA) is approved treatment for acute ischemic stroke
(ACR)
[1–8] [PREPRINTER stage]
Acta Radiol OnlineFirst, published on September 2, 2014 as doi:10.1177/0284185114545151
Original Article
Timing of recanalization and outcome in ischemic-stroke patients treated with recombinant tissue plasminogen activator
Acta Radiologica 0(0) 1–8 ! The Foundation Acta Radiologica 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/0284185114545151 acr.sagepub.com
Xiao-Er Wei1,*, Yu-Wu Zhao2,*, Jing Lu1, Ming-Hua Li1, Wen-Bin Li1, Ya-Jun Zhou2 and Yue-Hua Li1
Abstract Background: Intravenous administration of recombinant tissue plasminogen activator (rtPA) is approved treatment for acute ischemic stroke
